21健讯Daily｜誉衡药业与兴和制药签订推广协议；成都先导、奥精医疗股东减持

七印授权

14N5AKVFQCY4BGABOG82ZBZMO95QYOE0R1IHY7EZR7EBA3H88C

2025-05-26 23:42:23

article

89C19633FF5927B5043B83285636515D5B79243AB1006DC1E38ED446E56054A0

zh-CN

B5E56AF9C41B864248EB382D15B9E3B424D76147

18484293

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

e9149d325e933dbb3111cf8472ac85be2423bfb2e80d6f7b127634393ecf11f42685b04dad36f91bd144a5bc777eba655e9f41a589c42f5c76064fb0763746e41b

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"180000"},"type":"cm"}

yuanben_6834fc5fd0b329.67469921

原本认证

5WPXJGCOAPQJX84QIAE2FGCKC4ZSHUE3VTX77QTPFR2M0S3W41

https://www.yuanben.io/article/89789b91-9b57-4db9-91c3-1b848830f3ae

{"author":"广东南方财经控股有限公司","authorization_pub_key":"03db333a8335fc94ab2e27ec5b937827ece2e576ae219f93ea1083a9a4f8882dc2"}